US equities
|
MU
$1,088.00
▲+0.00%
META
$721.31
▲+0.00%
GOOGL
$350.50
▲+0.00%
NVDA
$237.47
▲+0.00%
SNDK
$1,692.42
▲+0.00%
INTC
$113.12
▲+0.00%
SPCX
$167.60
▲+0.00%
AMD
$645.86
▲+0.00%
MU
$1,088.00
▲+0.00%
META
$721.31
▲+0.00%
GOOGL
$350.50
▲+0.00%
NVDA
$237.47
▲+0.00%
SNDK
$1,692.42
▲+0.00%
INTC
$113.12
▲+0.00%
SPCX
$167.60
▲+0.00%
AMD
$645.86
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:APLS
Recent news which mentions NASDAQ:APLS
APLS Stock Earnings: Apellis Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
Tickers
APLS
Tags
APLS
NASDAQ:APLS
Earnings Reports
From
InvestorPlace
Apellis Pharmaceuticals stock has lost 40% in 2024: buy the dip?
April 30, 2024
Tickers
APLS
USA
Tags
Stock Market
USA
Trading Ideas
From
Invezz
Better Pharmaceutical Stock: Apellis or Novartis?
September 14, 2021
Tags
NYSE:NVS
NASDAQ:APLS
From
StockNews.com
APLS Stock: The Trial Results That Have Apellis Pharmaceuticals Plunging Today
September 10, 2021
Tickers
APLS
Tags
APLS
NASDAQ:APLS
Market News
From
InvestorPlace